{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:43:59Z","timestamp":1780447439470,"version":"3.54.1"},"reference-count":70,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Human papillomavirus (HPV) self-collection increases cervical cancer screening uptake among women underscreened for cervical cancer, particularly those from marginalized low-income and racial and ethnic backgrounds. Underscreened women are also at high risk for other sexually transmitted infections (STIs) that can be similarly screened via self-collection.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To evaluate an intervention streamlining testing for other STIs alongside HPV self-collected samples among low-income women.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This is a secondary analysis of the My Body, My Test\u20133 study, a randomized clinical trial testing a mailed self-collection intervention to improve cervical cancer screening. The My Body, My Test\u20133 study was conducted from April 2016 to December 2019 in 22 counties in North Carolina among low-income women overdue for cervical cancer screening. This analysis included participants randomized to the trial intervention group with valid STI and HPV results. Data analysis occurred from October 2024 to February 2025.<\/jats:p>\n <\/jats:sec>\n \n Intervention<\/jats:title>\n The intervention included a mailed self-collection kit and instructions to self-collect a cervicovaginal sample. Samples were tested for other STIs and HPV using the Aptima assay.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n The primary outcome was a positive test result for other STIs (including chlamydia, gonorrhea, and trichomoniasis). A risk factor analysis was conducted to identify factors associated with testing positive for other STIs. Secondary outcomes included rate of follow-up care and perceptions of self-collection among participants with positive STI results.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Among 327 participants (median [IQR] age, 42 [25-63] years; 38 [8.6%] Hispanic, 146 [44.7%] non-Hispanic Black, and 133 [40.7%] non-Hispanic White), 51 (15.6%) tested positive for other STIs and 51 (15.6%) tested positive for HPV; 7 (2.1%) tested positive for both. Risk factors for other STIs included non-Hispanic Black race and ethnicity compared with non-Hispanic White race and ethnicity (adjusted odds ratio [aOR], 4.1; 95% CI, 1.5-11.6), having 2 or more sexual partners in the last year compared with having none (aOR, 5.7; 95% CI, 1.0-31.4), single marital status compared with married or partnered status (aOR, 5.6; 95% CI, 1.1-27.9), and current smoking compared with none (aOR, 4.1; 95% CI, 1.7-10.4). Among participants who tested positive for other STIs, 34 (66.7%) received follow-up care. Most participants (130 [84.4%]) preferred testing for both HPV and other STIs in the future.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this secondary analysis of a randomized clinical trial of 327 participants, nearly 1 in 6 tested positive for other STIs via streamlined testing in a mailed HPV self-collection intervention. Self-collection may improve both cervical cancer and STI screening for women from marginalized backgrounds.<\/jats:p>\n <\/jats:sec>\n \n Trial Registration<\/jats:title>\n \n ClinicalTrials.gov Identifier:\n NCT02651883<\/jats:ext-link>\n <\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.51345","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T16:00:38Z","timestamp":1767888038000},"page":"e2551345","source":"Crossref","is-referenced-by-count":1,"title":["Streamlined Self-Collection Screening for Sexually Transmitted Infections and Human Papillomavirus"],"prefix":"10.1001","volume":"9","author":[{"given":"Anisha P.","family":"Ganguly","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, School of Medicine, University of North Carolina at Chapel Hill"},{"name":"Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peyton K.","family":"Pretsch","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noel T.","family":"Brewer","sequence":"additional","affiliation":[{"name":"Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill"},{"name":"Department of Health Behavior, Gillings School of Global Public Health, University of North Carolina at Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa P.","family":"Spees","sequence":"additional","affiliation":[{"name":"Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill"},{"name":"Division of Pharmaceutical Outcomes and Policy, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Hudgens","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Gillings School of Global Public Health, University of North Carolina at Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Busola","family":"Sanusi","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Gillings School of Global Public Health, University of North Carolina at Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"Barclay","sequence":"additional","affiliation":[{"name":"American Sexual Health Association, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Carter","sequence":"additional","affiliation":[{"name":"Laboratory Corporation of America Holdings, Burlington, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie B.","family":"Wheeler","sequence":"additional","affiliation":[{"name":"Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill"},{"name":"Department of Health Policy and Management, Gillings School of Global Public Health, University of North Carolina at Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer S.","family":"Smith","sequence":"additional","affiliation":[{"name":"Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill"},{"name":"Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,1,8]]},"reference":[{"issue":"11","key":"zoi251365r1","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1002\/cncr.25065","article-title":"Cervical cancer prevention: new tools and old barriers.","volume":"116","author":"Scarinci","year":"2010","journal-title":"Cancer"},{"key":"zoi251365r2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2020.106400","article-title":"Cervical cancer screening in the United States: challenges and potential solutions for underscreened groups.","volume":"144","author":"Fuzzell","year":"2021","journal-title":"Prev Med"},{"issue":"4","key":"zoi251365r3","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1007\/s10900-017-0316-9","article-title":"Cervical cancer screening barriers and risk factor knowledge among uninsured women.","volume":"42","author":"Akinlotan","year":"2017","journal-title":"J Community Health"},{"issue":"8","key":"zoi251365r4","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1089\/jwh.2018.7141","article-title":"Predictors of cervical cancer screening among infrequently screened women completing human papillomavirus self-collection: My Body My Test-1.","volume":"28","author":"Lea","year":"2019","journal-title":"J Womens Health (Larchmt)"},{"issue":"12","key":"zoi251365r5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0277791","article-title":"Patient perspectives on cervical cancer screening interventions among underscreened women.","volume":"17","author":"Des Marais","year":"2022","journal-title":"PLoS One"},{"issue":"2","key":"zoi251365r7","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.idc.2023.02.001","article-title":"Trichomoniasis.","volume":"37","author":"Van Gerwen","year":"2023","journal-title":"Infect Dis Clin North Am"},{"issue":"2","key":"zoi251365r9","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1097\/OLQ.0b013e31827c08c3","article-title":"A Trich-y question: should Trichomonas vaginalis infection be reportable?","volume":"40","author":"Hoots","year":"2013","journal-title":"Sex Transm Dis"},{"key":"zoi251365r10","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-155-10-201111150-00377","author":"Vesco","year":"2011","journal-title":"Ann Intern Med"},{"issue":"3","key":"zoi251365r11","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jinf.2012.10.024","article-title":"Risk factors for and prevention of human papillomaviruses (HPV), genital warts and cervical cancer.","volume":"66","author":"Chelimo","year":"2013","journal-title":"J Infect"},{"issue":"3","key":"zoi251365r12","first-page":"242s","article-title":"Cervical cancer: disparities in screening, treatment, and survival.","volume":"12","author":"Garner","year":"2003","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"8","key":"zoi251365r13","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/0277-9536(92)90254-N","article-title":"Behavioral risk factors for sexually transmitted diseases in American households.","volume":"34","author":"Ericksen","year":"1992","journal-title":"Soc Sci Med"},{"issue":"9907","key":"zoi251365r14","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1016\/S0140-6736(13)61947-9","article-title":"Prevalence, risk factors, and uptake of interventions for sexually transmitted infections in Britain: findings from the National Surveys of Sexual Attitudes and Lifestyles (Natsal).","volume":"382","author":"Sonnenberg","year":"2013","journal-title":"Lancet"},{"issue":"8","key":"zoi251365r15","doi-asserted-by":"publisher","first-page":"e235","DOI":"10.1016\/S1473-3099(17)30310-9","article-title":"Sexually transmitted infections: challenges ahead.","volume":"17","author":"Unemo","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"zoi251365r16","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2018-001351","article-title":"Self-sampling for human papillomavirus (HPV) testing: a systematic review and meta-analysis.","volume":"4","author":"Yeh","year":"2019","journal-title":"BMJ Glob Health"},{"issue":"2","key":"zoi251365r17","doi-asserted-by":"publisher","first-page":"e159","DOI":"10.1007\/BF03405681","article-title":"Self-collected HPV testing improves participation in cervical cancer screening: a systematic review and meta-analysis.","volume":"104","author":"Racey","year":"2013","journal-title":"Can J Public Health"},{"key":"zoi251365r18","doi-asserted-by":"publisher","first-page":"k4823","DOI":"10.1136\/bmj.k4823","article-title":"Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses.","volume":"363","author":"Arbyn","year":"2018","journal-title":"BMJ"},{"issue":"6","key":"zoi251365r19","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/bjc.2011.48","article-title":"HPV self-sampling as an alternative strategy in non-attenders for cervical screening\u2014a randomised controlled trial.","volume":"104","author":"Szarewski","year":"2011","journal-title":"Br J Cancer"},{"issue":"11","key":"zoi251365r20","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.14729","article-title":"Effect of mailed human papillomavirus test kits vs usual care reminders on cervical cancer screening uptake, precancer detection, and treatment: a randomized clinical trial.","volume":"2","author":"Winer","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"6","key":"zoi251365r21","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1097\/AOG.0000000000002964","article-title":"Home self-collection by mail to test for human papillomavirus and sexually transmitted infections.","volume":"132","author":"Des Marais","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"1","key":"zoi251365r22","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1097\/OLQ.0000000000000681","article-title":"Mailed human papillomavirus self-collection with Papanicolaou test referral for infrequently screened women in the United States.","volume":"45","author":"Smith","year":"2018","journal-title":"Sex Transm Dis"},{"issue":"1","key":"zoi251365r23","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1186\/s12885-018-4165-4","article-title":"Preventing cervical cancer using HPV self-sampling: direct mailing of test-kits increases screening participation more than timely opt-in procedures\u2014a randomized controlled trial.","volume":"18","author":"Tranberg","year":"2018","journal-title":"BMC Cancer"},{"issue":"7","key":"zoi251365r24","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1001\/jama.2018.10897","article-title":"Screening for cervical cancer: US Preventive Services Task Force recommendation statement.","volume":"320","author":"Curry","year":"2018","journal-title":"JAMA"},{"issue":"10","key":"zoi251365r27","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1001\/jama.2021.14081","article-title":"Screening for chlamydia and gonorrhea: US Preventive Services Task Force recommendation statement.","volume":"326","author":"Davidson","year":"2021","journal-title":"JAMA"},{"issue":"2","key":"zoi251365r28","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2018-001349","article-title":"Self-collection of samples as an additional approach to deliver testing services for sexually transmitted infections: a systematic review and meta-analysis.","volume":"4","author":"Ogale","year":"2019","journal-title":"BMJ Glob Health"},{"issue":"11","key":"zoi251365r29","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02646-20","article-title":"At-home specimen self-collection and self-testing for sexually transmitted infection screening demand accelerated by the COVID-19 pandemic: a review of laboratory implementation issues.","volume":"59","author":"Kersh","year":"2021","journal-title":"J Clin Microbiol"},{"issue":"1","key":"zoi251365r30","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1186\/s13063-019-3959-2","article-title":"Impact of human papillomavirus (HPV) self-collection on subsequent cervical cancer screening completion among under-screened US women: MyBodyMyTest-3 protocol for a randomized controlled trial.","volume":"20","author":"Spees","year":"2019","journal-title":"Trials"},{"issue":"6","key":"zoi251365r31","doi-asserted-by":"publisher","first-page":"e411","DOI":"10.1016\/S2468-2667(23)00076-2","article-title":"Effect of HPV self-collection kits on cervical cancer screening uptake among under-screened women from low-income US backgrounds (MBMT-3): a phase 3, open-label, randomised controlled trial.","volume":"8","author":"Pretsch","year":"2023","journal-title":"Lancet Public Health"},{"issue":"3","key":"zoi251365r32","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/OLQ.0000000000001557","article-title":"Prevalence of high-risk human papillomavirus by RNA assay in home self-collected samples among underscreened people in North Carolina.","volume":"49","author":"Lee","year":"2022","journal-title":"Sex Transm Dis"},{"issue":"11","key":"zoi251365r33","doi-asserted-by":"publisher","first-page":"726","DOI":"10.7326\/0003-4819-152-11-201006010-00232","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials.","volume":"152","author":"Schulz","year":"2010","journal-title":"Ann Intern Med"},{"issue":"12","key":"zoi251365r34","doi-asserted-by":"publisher","first-page":"902","DOI":"10.7326\/M14-1981","article-title":"Screening for chlamydia and gonorrhea: U.S. Preventive Services Task Force recommendation statement.","volume":"161","author":"LeFevre","year":"2014","journal-title":"Ann Intern Med"},{"key":"zoi251365r35","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.ejogrb.2018.06.031","article-title":"Trichomonas vaginalis infection-associated risk of cervical cancer: a meta-analysis.","volume":"228","author":"Yang","year":"2018","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"zoi251365r36","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/ijgo.14763","article-title":"Trichomonas vaginalis infection is associated with increased risk of cervical carcinogenesis: a systematic review and meta-analysis of 470?000 patients.","volume":"163","author":"Hamar","year":"2023","journal-title":"Int J Gynaecol Obstet"},{"issue":"4","key":"zoi251365r37","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1097\/LGT.0000000000000430","article-title":"Preference for human papillomavirus self-collection and Papanicolaou: survey of underscreened women in North Carolina.","volume":"22","author":"Kilfoyle","year":"2018","journal-title":"J Low Genit Tract Dis"},{"key":"zoi251365r38","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ypmed.2019.04.025","article-title":"Experience with HPV self-sampling and clinician-based sampling in women attending routine cervical screening in the Netherlands.","volume":"125","author":"Polman","year":"2019","journal-title":"Prev Med"},{"issue":"4","key":"zoi251365r39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0124310","article-title":"Obtaining self-samples to diagnose curable sexually transmitted infections: a systematic review of patients\u2019 experiences.","volume":"10","author":"Paudyal","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"zoi251365r40","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.jadohealth.2016.01.002","article-title":"Sexually transmitted infection testing among adolescents and young adults in the United States.","volume":"58","author":"Cuffe","year":"2016","journal-title":"J Adolesc Health"},{"issue":"4","key":"zoi251365r41","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1080\/07448480209596021","article-title":"Social stigma and negative consequences: factors that influence college students\u2019 decisions to seek testing for sexually transmitted infections.","volume":"50","author":"Barth","year":"2002","journal-title":"J Am Coll Health"},{"issue":"4","key":"zoi251365r42","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1177\/0033354920925094","article-title":"Persistent disparities in cervical cancer screening uptake: knowledge and sociodemographic determinants of Papanicolaou and human papillomavirus testing among women in the united states.","volume":"135","author":"Johnson","year":"2020","journal-title":"Public Health Rep"},{"issue":"1","key":"zoi251365r43","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/sextrans-2016-052609","article-title":"The acceptability of self-sampled screening for HPV DNA: a systematic review and meta-analysis.","volume":"93","author":"Nelson","year":"2017","journal-title":"Sex Transm Infect"},{"issue":"4","key":"zoi251365r44","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1097\/LGT.0b013e3181dc115b","article-title":"Self-collection for vaginal human papillomavirus testing: systematic review of studies asking women their perceptions.","volume":"14","author":"Huynh","year":"2010","journal-title":"J Low Genit Tract Dis"},{"issue":"1","key":"zoi251365r45","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1097\/OLQ.0000000000001313","article-title":"At-home testing for sexually transmitted infections during the COVID-19 pandemic.","volume":"48","author":"Carnevale","year":"2021","journal-title":"Sex Transm Dis"},{"issue":"6","key":"zoi251365r46","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1097\/OLQ.0000000000001787","article-title":"Landscape review of mail-in self-collection, programs for sexually transmitted infections.","volume":"50","author":"Pontes","year":"2023","journal-title":"Sex Transm Dis"},{"issue":"74","key":"zoi251365r47","doi-asserted-by":"publisher","first-page":"S89","DOI":"10.1093\/cid\/ciab1055","article-title":"Centers for Disease Control and Prevention\u2019s sexually transmitted diseases infection guidelines.","volume":"74","author":"Workowski","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"2","key":"zoi251365r48","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1097\/LGT.0000000000000885","article-title":"Self-collected vaginal specimens for HPV testing: recommendations from the Enduring Consensus Cervical Cancer Screening and Management Guidelines Committee.","volume":"29","author":"Wentzensen","year":"2025","journal-title":"J Low Genit Tract Dis"},{"issue":"8","key":"zoi251365r49","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1158\/1055-9965.EPI-22-1267","article-title":"Cost-effectiveness of human papillomavirus self-collection intervention on cervical cancer screening uptake among underscreened U.S. persons with a cervix.","volume":"32","author":"Spees","year":"2023","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"9","key":"zoi251365r50","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-020394","article-title":"Modelling-based evaluation of the costs, benefits and cost-effectiveness of multipathogen point-of-care tests for sexually transmitted infections in symptomatic genitourinary medicine clinic attendees.","volume":"8","author":"Huntington","year":"2018","journal-title":"BMJ Open"},{"issue":"5","key":"zoi251365r52","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.11081","article-title":"Clinical validation of a vaginal cervical cancer screening self-collection method for at-home use: a nonrandomized clinical trial.","volume":"8","author":"Fitzpatrick","year":"2025","journal-title":"JAMA Netw Open"},{"key":"zoi251365r54","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ypmed.2018.08.007","article-title":"Improving STD service delivery: would American patients and providers use self-tests for gonorrhea and chlamydia?","volume":"115","author":"Pearson","year":"2018","journal-title":"Prev Med"},{"issue":"8S","key":"zoi251365r55","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.1097\/OLQ.0000000000001457","article-title":"A narrative review of where we are with point-of-care sexually transmitted infection testing in the United States.","volume":"48","author":"Gaydos","year":"2021","journal-title":"Sex Transm Dis"},{"issue":"5","key":"zoi251365r56","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/S1473-3099(20)30790-8","article-title":"Accurate, rapid, point-of-care tests for sexually transmitted infections.","volume":"21","author":"Unemo","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"zoi251365r57","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1038\/s41564-022-01177-x","article-title":"Sexually transmitted infections and female reproductive health.","volume":"7","author":"Van Gerwen","year":"2022","journal-title":"Nat Microbiol"},{"issue":"13","key":"zoi251365r58","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003077","article-title":"Chlamydia trachomatis infection-associated risk of cervical cancer: a meta-analysis.","volume":"95","author":"Zhu","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"zoi251365r59","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/ijc.20257","article-title":"Chlamydia trachomatis and invasive cervical cancer: a pooled analysis of the IARC multicentric case-control study.","volume":"111","author":"Smith","year":"2004","journal-title":"Int J Cancer"},{"key":"zoi251365r60","doi-asserted-by":"publisher","first-page":"S115","DOI":"10.1086\/425280","article-title":"Social context, sexual networks, and racial disparities in rates of sexually transmitted infections.","volume":"191","author":"Adimora","year":"2005","journal-title":"J Infect Dis"},{"issue":"2","key":"zoi251365r61","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.nwh.2022.01.006","article-title":"A systematic review exploring racial disparities, social determinants of health, and sexually transmitted infections in Black women.","volume":"26","author":"Cohn","year":"2022","journal-title":"Nurs Womens Health"},{"issue":"12","key":"zoi251365r62","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.3390\/ijerph15122819","article-title":"STI health disparities: a systematic review and meta-analysis of the effectiveness of preventive interventions in educational settings.","volume":"15","author":"Mon Kyaw Soe","year":"2018","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"zoi251365r63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/OLQ.0000000000001695","article-title":"The importance of structural interventions for advancing sexual health and health equity in the United States: a review of the evidence and recommendations for action on sexually transmitted infections.","volume":"50","author":"Ag\u00e9nor","year":"2023","journal-title":"Sex Transm Dis"},{"issue":"5","key":"zoi251365r64","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/OLQ.0000000000001600","article-title":"Rates of appropriate treatment and follow-up testing after a gonorrhea and\/or chlamydia infection in an urban network of federally qualified health center systems.","volume":"49","author":"McWhirter","year":"2022","journal-title":"Sex Transm Dis"},{"key":"zoi251365r65","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1471-2334-13-30","article-title":"Systematic screening with information and home sampling for genital Chlamydia trachomatis infections in young men and women in Norway: a randomized controlled trial.","volume":"13","author":"Kl\u00f8vstad","year":"2013","journal-title":"BMC Infect Dis"},{"issue":"3","key":"zoi251365r66","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1089\/jwh.2006.0161","article-title":"Understanding barriers for adherence to follow-up care for abnormal pap tests.","volume":"16","author":"Eggleston","year":"2007","journal-title":"J Womens Health (Larchmt)"},{"issue":"11","key":"zoi251365r67","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1007\/s11606-010-1450-6","article-title":"Barriers to follow-up of an abnormal Pap smear in Latina women referred for colposcopy.","volume":"25","author":"Percac-Lima","year":"2010","journal-title":"J Gen Intern Med"},{"issue":"6","key":"zoi251365r68","doi-asserted-by":"publisher","first-page":"e394","DOI":"10.1016\/S2468-2667(23)00094-4","article-title":"The HPV self-collection paradox: boosting cervical cancer screening, struggling with follow-up care.","volume":"8","author":"Wang","year":"2023","journal-title":"Lancet Public Health"},{"issue":"10","key":"zoi251365r69","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1158\/1055-9965.EPI-12-0535","article-title":"Follow-up and timeliness after an abnormal cancer screening among underserved, urban women in a patient navigation program.","volume":"21","author":"Markossian","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"10","key":"zoi251365r70","first-page":"1015","article-title":"Abnormal Pap smear follow-up in a high-risk population.","volume":"10","author":"Engelstad","year":"2001","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"zoi251365r6","unstructured":"US Centers for Disease Control and Prevention. Sexually Transmitted Infections Surveillance, 2024 (provisional). September 24, 2025. Accessed April 21, 2025. https:\/\/www.cdc.gov\/sti-statistics\/annual\/index.html"},{"key":"zoi251365r8","unstructured":"US Centers for Disease Control and Prevention. Reporting and confidentiality. July 22, 2021. Accessed October 5, 2025. https:\/\/www.cdc.gov\/std\/treatment-guidelines\/clinical-reporting.htm"},{"key":"zoi251365r25","unstructured":"American College of Obstetrics and Gynecology. Updated cervical cancer screening guidelines. April 2021. Accessed October 5, 2025. https:\/\/www.acog.org\/clinical\/clinical-guidance\/practice-advisory\/articles\/2021\/04\/updated-cervical-cancer-screening-guidelines"},{"key":"zoi251365r26","unstructured":"American Society for Colposcopy and Cervical Pathology. ASCCP 2019 risk based management consensus guidelines. April 2020. Accessed October 5, 2025. https:\/\/www.asccp.org\/enduring-guidelines\/asccp-2019-risk-based-management"},{"key":"zoi251365r51","unstructured":"Reynolds? S. FDA approves HPV tests that allow for self-collection in a health care setting. National Cancer Institute. July 24, 2024. Accessed September 15, 2025. https:\/\/www.cancer.gov\/news-events\/cancer-currents-blog\/2024\/fda-hpv-test-self-collection-health-care-setting"},{"key":"zoi251365r53","unstructured":"McKinney? J. FDA grants marketing authorization of first home test for chlamydia, gonorrhea and trichomoniasis. US Food and Drug Administration. March 28, 2025. Accessed September 19, 2025. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-grants-marketing-authorization-first-home-test-chlamydia-gonorrhea-and-trichomoniasis"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2843541\/ganguly_2026_oi_251365_1767025251.07553.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T16:00:40Z","timestamp":1767888040000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2843541"}},"subtitle":["A Single-Group Secondary Analysis of a Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2026,1,8]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.51345","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,8]]}}}